Cases 21 - 30 of 56
Boehringer Ingelheim Pharmaceuticals Inc. v Cipla Limited et al
as 1:2019cv01494
Defendant:
Cipla USA, Inc. and Cipla Limited
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
In re: Sensipar (Cinacalcet Hydrochloride Tablets) Antitrust Litigation
as 1:2019md02895
Not Classified By Court:
UFCW Local 1500 Welfare Fund, Actavis Pharma Inc., Cipla Ltd. and others
Plaintiff:
Cesar Castillo, Inc. and KPH HEALTHCARE SERVICES, INC.
In Re:
In re: Sensipar (Cinacalcet Hydrochloride Tablets) Antitrust Litigation
Cause Of Action: 15 U.S.C. § 1
Pfizer Inc. et al. v. Cipla USA Inc. et al.
as 1:2019cv00749
Plaintiff:
Pfizer Manufacturing Holdings LLC, Pfizer PFE Ireland Pharmaceuticals Holding 1 B.V., Pfizer Inc. and others
Defendant:
Cipla, Ltd. and Cipla USA Inc.
Cause Of Action: 35 U.S.C. § 271
Cipla Limited et al v. AstraZeneca AB et al
as 1:2019cv00733
Defendant:
AstraZeneca AB, Aktiebolaget Hassle, AstraZeneca Pharmaceuticals LP and others
Plaintiff:
Cipla Limited and Cipla USA, Inc.
Cause Of Action: 35 U.S.C. § 271
In re: Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
as 1:2019md02884
Counter Claimant:
Glasshouse Pharmaceuticals Limited Canada
Not Classified By Court:
Taro Pharmaceuticals U.S.A., Inc., Aurobindo Pharma Limited, Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
Counter Defendant:
Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Cipla Limited et al v. AstraZeneca AB et al
as 1:2019cv00438
Defendant:
AstraZeneca AB, Aktiebolaget Hassle, AstraZeneca Pharmaceuticals LP and others
Plaintiff:
Cipla Limited and Cipla USA, Inc.
Cause Of Action: 28 U.S.C. § 2201
Genentech, Inc. et al v. InvaGen Pharmaceuticals, Inc., et al.
as 1:2019cv00219
Plaintiff:
Genentech, Inc. and InterMune, Inc.
Defendant:
Cipla Limited, InvaGen Pharmaceuticals, Inc. and Cipla USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Cipla Ltd. et al v. Amgen Inc.
as 1:2019cv00044
Defendant:
Amgen Inc. and Teva Pharmaceuticals USA, Inc.
Plaintiff:
Cipla USA, Inc. and Cipla Ltd.
Cause Of Action: 15 U.S.C. § 1
Genzyme Corp. et al v. Cipla Limited
as 1:2018cv01838
Plaintiff:
The Regents of the University of Michigan and Genzyme Corp.
Defendant:
Cipla Limited
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Cipla Limited et al
as 1:2018cv01789
Defendant:
Cipla USA, Inc. and Cipla Limited
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
